+63,849.1%
AMGN vs GSK
+1,698.4%
+62,150.7%
-60.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | -2.3% | +1.4% | 0.0% |
| 7D | -1.6% | -3.0% | +1.4% | -0.3% |
| 30D | +5.9% | +0.4% | +5.5% | +5.7% |
| 3M | +9.8% | -1.2% | +11.0% | +10.4% |
| 6M | +41.2% | +0.9% | +40.2% | +40.6% |
| YTD | +42.8% | +4.0% | +38.8% | +40.4% |
| 1Y | +37.7% | +7.3% | +30.4% | +33.7% |
| 3Y | +87.3% | +57.1% | +30.2% | +53.7% |
| 5Y | +157.8% | +43.0% | +114.8% | +115.6% |
| 10Y | +315.9% | +103.1% | +212.9% | +199.4% |
| All | +63,849.1% | +1,698.4% | +62,150.7% | +17,408.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling